Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
about
Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@en
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@nl
type
label
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@en
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@nl
prefLabel
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@en
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@nl
P2093
P2860
P1476
Inhibition and reversal of pla ...... ts of Abciximab and Lamifiban.
@en
P2093
Benoit Labarthe
Chantal Legrand
Mony Frojmovic
P2860
P304
P356
10.1111/J.1365-2141.2005.05782.X
P407
P577
2005-11-01T00:00:00Z